000 01180 a2200301 4500
005 20250513224347.0
264 0 _c20010108
008 200101s 0 0 eng d
022 _a1354-3784
024 7 _a10.1517/13543784.9.12.2923
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGore, S D
245 0 0 _aModifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.
_h[electronic resource]
260 _bExpert opinion on investigational drugs
_cDec 2000
300 _a2923-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPhenylbutyrates
_xpharmacology
700 1 _aCarducci, M A
773 0 _tExpert opinion on investigational drugs
_gvol. 9
_gno. 12
_gp. 2923-34
856 4 0 _uhttps://doi.org/10.1517/13543784.9.12.2923
_zAvailable from publisher's website
999 _c11034916
_d11034916